Cagrilintide + Retatrutide

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

117

authors mention this stack

56

ran the components concurrently

Cagrilintide + Retatrutide (Cagrilintide + Retatrutide) appears in 117 author journeys (56 as actual concurrent use). Common goals: Weight loss and appetite suppression; weight loss; appetite suppression. Typical doses reported: Cagrilintide 0.5mg, Retatrutide 5mg. Reported side effects include: unstated

Typical doses reported

Community-reported doses are not medical guidance.

How people are running it

37

Recommended / discussed

37

Currently running

27

Planning to run

22

Ran in the past

What people use it for

Weight loss and appetite suppressionweight lossappetite suppressionweight loss and appetite suppressionappetite suppression and weight lossweight loss, appetite suppression

Sample reported outcomes

  • unstated
  • Not yet realized
  • Down 63 lbs (SW: 270 lbs, CW: 207 lbs)
  • Suppressed appetite ('can’t think about eating'); down 70 lbs after 6 months
  • Successfully broke through weight loss plateau; weight down from 260 lbs to 198 lbs
  • Zero hunger suppression; felt no effect from either peptide
  • Not yet started
  • successfully maintaining weight at 225 lbs (down from starting weight of 350 lbs)

Self-reported community experiences, not verified results.

Sample reported side effects

  • unstated
  • Not yet realized
  • None specified
  • None
  • Not yet started
  • diarrhea from Cagrilintide, zero fatigue
  • Overactive libido, nausea/aversion to fried food
  • unspecified